Skip to main content
. 2019 Mar 29;10(25):2475–2483. doi: 10.18632/oncotarget.26810

Figure 1.

Figure 1

Incidence of breast cancer among BRCA1 and BRCA2 mutation carriers with high (>5.24 pg/ml) vs. low (≤5.24 pg/ml) plasma RANKL levels.